Charles S Fuchs Selected Research

Aspirin (Acetylsalicylic Acid)

1/2022	Association Between Aspirin Use and Gastric Adenocarcinoma: A Prospective Cohort Study.
1/2021	Effect of Celecoxib vs Placebo Added to Standard Adjuvant Therapy on Disease-Free Survival Among Patients With Stage III Colon Cancer: The CALGB/SWOG 80702 (Alliance) Randomized Clinical Trial.
12/2018	Association Between Aspirin Use and Risk of Hepatocellular Carcinoma.
1/2018	Regular Use of Aspirin or Non-Aspirin Nonsteroidal Anti-Inflammatory Drugs Is Not Associated With Risk of Incident Pancreatic Cancer in Two Large Cohort Studies.
10/2017	Aspirin exerts high anti-cancer activity in PIK3CA-mutant colon cancer cells.
6/2017	Aspirin Use and Colorectal Cancer Survival According to Tumor CD274 (Programmed Cell Death 1 Ligand 1) Expression Status.
11/2016	Regular Aspirin Use Associates With Lower Risk of Colorectal Cancers With Low Numbers of Tumor-Infiltrating Lymphocytes.
6/2016	Population-wide Impact of Long-term Use of Aspirin and the Risk for Cancer.
1/2016	MicroRNA MIR21 (miR-21) and PTGS2 Expression in Colorectal Cancer and Patient Survival.
12/2015	NSAID Use and Risk of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: The Liver Cancer Pooling Project.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Charles S Fuchs Research Topics

Disease

241	Colorectal Neoplasms (Colorectal Cancer) 08/2023 - 03/2002
229	Neoplasms (Cancer) 04/2022 - 01/2002
87	Colonic Neoplasms (Colon Cancer) 10/2023 - 03/2002
67	Microsatellite Instability 06/2021 - 01/2006
55	Carcinogenesis 10/2021 - 09/2002
51	Pancreatic Neoplasms (Pancreatic Cancer) 10/2023 - 01/2002
37	Adenocarcinoma 01/2022 - 12/2005
32	Adenoma (Adenomas) 01/2021 - 03/2002
19	Carcinoma (Carcinomatosis) 01/2019 - 08/2003
19	Rectal Neoplasms (Rectal Cancer) 11/2018 - 04/2003
15	Obesity 10/2023 - 08/2003
14	Inflammation (Inflammations) 01/2023 - 03/2010
14	Stomach Neoplasms (Stomach Cancer) 01/2022 - 04/2002
12	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2022 - 09/2004
12	Hepatocellular Carcinoma (Hepatoma) 01/2019 - 06/2002
11	Disease Progression 01/2022 - 12/2008
11	Hypertension (High Blood Pressure) 01/2022 - 11/2005
10	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 02/2004
9	Neutropenia 07/2023 - 01/2004
8	Crohn Disease (Crohn's Disease) 01/2022 - 03/2012
8	Leukemia 01/2022 - 09/2008
8	Polyps 01/2021 - 07/2004
8	Insulin Resistance 02/2020 - 11/2005
7	Diarrhea 07/2023 - 01/2003
7	Hyperinsulinism (Hyperinsulinemia) 08/2020 - 04/2005
7	Overweight 06/2015 - 09/2002
7	Ulcerative Colitis 06/2015 - 03/2012
7	Carcinoid Tumor (Carcinoid) 08/2012 - 01/2004
6	Neoplasm Metastasis (Metastasis) 12/2017 - 08/2006
5	Nausea 07/2023 - 01/2003
5	Lung Neoplasms (Lung Cancer) 01/2019 - 09/2005

Drug/Important Bio-Agent (IBA)

51	Biomarkers (Surrogate Marker)IBA 06/2021 - 06/2005
40	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2021 - 01/2006
38	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 08/2002
31	Fluorouracil (Carac)FDA LinkGeneric 10/2023 - 04/2002
29	Vitamin D FDA LinkGeneric 01/2023 - 09/2004
28	Irinotecan (Camptosar)FDA LinkGeneric 07/2023 - 03/2003
25	NucleotidesIBA 08/2020 - 07/2007
25	Folic Acid (Vitamin M)FDA LinkGeneric 12/2015 - 03/2002
23	DNA (Deoxyribonucleic Acid)IBA 10/2022 - 05/2005
22	25-hydroxyvitamin DIBA 01/2023 - 09/2004
21	hydroxide ionIBA 01/2023 - 09/2004
20	Insulin (Novolin)FDA Link 01/2021 - 01/2005
19	Leucovorin (Folinic Acid)FDA Link 10/2023 - 01/2003
17	Oxaliplatin (Eloxatin)FDA LinkGeneric 10/2023 - 01/2003
17	C-PeptideIBA 08/2020 - 01/2005
17	beta CateninIBA 10/2018 - 07/2007
15	Fatty Acid Synthases (Fatty Acid Synthase)IBA 03/2012 - 01/2006
14	pembrolizumabIBA 01/2022 - 01/2018
13	ErbB Receptors (EGF Receptor)IBA 08/2021 - 12/2004
13	Proteins (Proteins, Gene)FDA Link 03/2018 - 06/2005
13	CarbonIBA 11/2015 - 12/2004
12	TabletsIBA 01/2022 - 08/2002
12	Cisplatin (Platino)FDA LinkGeneric 08/2021 - 04/2002
12	CalciumIBA 01/2020 - 03/2002
12	Gemcitabine FDA Link 01/2019 - 01/2002
12	Insulin-Like PeptidesIBA 03/2016 - 04/2005
11	Bevacizumab (Avastin)FDA Link 01/2022 - 12/2005
11	ParaffinIBA 01/2020 - 08/2005
11	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2018 - 08/2002
11	Hormones (Hormone)IBA 01/2016 - 08/2002
10	AdiponectinIBA 10/2023 - 11/2005
10	RamucirumabIBA 10/2020 - 01/2014
10	CateninsIBA 01/2018 - 03/2011
10	EnzymesIBA 01/2016 - 08/2004
9	Coffee FDA Link 01/2022 - 02/2005
9	Cetuximab (Erbitux)FDA Link 01/2022 - 05/2006
9	Cyclin D1IBA 03/2011 - 01/2009
8	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 12/2005
8	PlatinumIBA 08/2021 - 08/2003
8	Monoclonal AntibodiesIBA 01/2019 - 12/2005
7	ORALIT (ORS)IBA 01/2023 - 02/2010
7	Capecitabine (Xeloda)FDA Link 08/2021 - 01/2003
7	LigandsIBA 08/2021 - 12/2005
7	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 12/2020 - 11/2014
7	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2018 - 03/2010
7	Tumor Biomarkers (Tumor Markers)IBA 12/2017 - 06/2012
7	Tyrosine Kinase InhibitorsIBA 03/2013 - 09/2005
6	SugarsIBA 01/2021 - 06/2004
6	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2018 - 07/2009
6	Vitamin B 6IBA 04/2013 - 05/2005
6	Methionine (L-Methionine)FDA Link 01/2011 - 03/2002
5	Paclitaxel (Taxol)FDA LinkGeneric 01/2022 - 10/2017
5	IronIBA 10/2021 - 06/2005
5	Interleukin-6 (Interleukin 6)IBA 01/2021 - 05/2013
5	Cholecalciferol (Vitamin D3)FDA Link 01/2021 - 02/2014
5	Dinoprostone (PGE2)FDA Link 01/2019 - 03/2010
5	Indicators and Reagents (Reagents)IBA 12/2018 - 04/2006
5	Dietary Fiber FDA Link 01/2018 - 12/2005
5	Oral ContraceptivesIBA 01/2016 - 08/2002
5	ElementsIBA 11/2015 - 04/2011
5	Everolimus FDA Link 07/2013 - 01/2009

Therapy/Procedure

74	Therapeutics 08/2023 - 04/2002
61	Drug Therapy (Chemotherapy) 01/2022 - 01/2002
28	Adjuvant Chemotherapy 01/2022 - 08/2002
9	Radiotherapy 11/2017 - 04/2003
7	Immunotherapy 06/2021 - 01/2016
6	Precision Medicine 01/2020 - 08/2011
6	Chemoprevention 11/2015 - 03/2005
6	Combination Drug Therapy (Combination Chemotherapy) 05/2007 - 01/2004